MH
Therapeutic Areas
AFFiRiS Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AFFITOPE® AT04 (licensed to Frontier Biotech) | Hypercholesterolemia | Phase 1 |
| PD01 (acquired by AC Immune) | Parkinson's Disease | Phase 1 |
| Anti-alpha-synuclein program for MSA (acquired by AC Immune) | Multiple System Atrophy (MSA) | Phase 1 |